{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:23:39Z","timestamp":1761060219456},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNCI J Natl Cancer Inst"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1093\/jnci\/djw281","type":"journal-article","created":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T15:05:37Z","timestamp":1477494337000},"page":"djw281","source":"Crossref","is-referenced-by-count":5,"title":["Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer"],"prefix":"10.1093","volume":"109","author":[{"given":"Nataniel H.","family":"Lester-Coll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Skyler","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Magnuson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel Z.","family":"Goldhaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Sher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony V.","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,12,31]]},"reference":[{"key":"2016123117301577000_109.6.djw281.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810095"},{"key":"2016123117301577000_109.6.djw281.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70223-0"},{"key":"2016123117301577000_109.6.djw281.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.04.075"},{"key":"2016123117301577000_109.6.djw281.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70063-8"},{"key":"2016123117301577000_109.6.djw281.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(96)00513-5"},{"issue":"3","key":"2016123117301577000_109.6.djw281.6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1200\/JCO.1997.15.3.1013","article-title":"Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of Radiation Therapy Oncology Group Protocol 85-31","volume":"15","author":"Pilepich","year":"1997","journal-title":"J Clin Oncol."},{"key":"2016123117301577000_109.6.djw281.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61815-2"},{"key":"2016123117301577000_109.6.djw281.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70045-8"},{"key":"2016123117301577000_109.6.djw281.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.7.821"},{"key":"2016123117301577000_109.6.djw281.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012348"},{"key":"2016123117301577000_109.6.djw281.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.02.073"},{"key":"2016123117301577000_109.6.djw281.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.03.049"},{"key":"2016123117301577000_109.6.djw281.13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70040-3"},{"key":"2016123117301577000_109.6.djw281.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.06.054"},{"key":"2016123117301577000_109.6.djw281.15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.8475"},{"key":"2016123117301577000_109.6.djw281.16","unstructured":"Martinez AA. A phase III prospective randomized trial of dose-escalated radiotherapy with or without short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer. https:\/\/www.rtog.org\/ClinicalTrials\/ProtocolTable\/StudyDetails.aspx?study=0815. Accessed May 14, 2016."},{"key":"2016123117301577000_109.6.djw281.17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.8055"},{"key":"2016123117301577000_109.6.djw281.18","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp404"},{"key":"2016123117301577000_109.6.djw281.19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1137"},{"key":"2016123117301577000_109.6.djw281.20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.1494"},{"key":"2016123117301577000_109.6.djw281.21","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22933"},{"key":"2016123117301577000_109.6.djw281.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.07.035"},{"key":"2016123117301577000_109.6.djw281.23","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm168"},{"key":"2016123117301577000_109.6.djw281.24","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25597"},{"key":"2016123117301577000_109.6.djw281.25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.1792"},{"issue":"6","key":"2016123117301577000_109.6.djw281.26","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.eururo.2014.09.028","article-title":"The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy","volume":"67","author":"Zumsteg","year":"2015","journal-title":"Eur Urol."},{"key":"2016123117301577000_109.6.djw281.27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.8577"},{"key":"2016123117301577000_109.6.djw281.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2012.09.008"},{"key":"2016123117301577000_109.6.djw281.29","first-page":"129","article-title":"Cardiovascular effects of hormone therapy for prostate cancer","volume":"7","author":"Lester","year":"2015","journal-title":"Drug Healthc Patient Saf."},{"key":"2016123117301577000_109.6.djw281.30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.051003698"},{"key":"2016123117301577000_109.6.djw281.31","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12454579"},{"issue":"10","key":"2016123117301577000_109.6.djw281.32","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/cncr.27980","article-title":"Death from high-risk prostate cancer versus cardiovascular mortality with hormonal therapy: A decision analysis","volume":"119","author":"Lester-Coll","year":"2013","journal-title":"Cancer."},{"key":"2016123117301577000_109.6.djw281.33","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-6-200503150-00005"},{"key":"2016123117301577000_109.6.djw281.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.10.082"},{"key":"2016123117301577000_109.6.djw281.35","doi-asserted-by":"publisher","DOI":"10.1002\/pros.20341"},{"key":"2016123117301577000_109.6.djw281.36","doi-asserted-by":"publisher","DOI":"10.2165\/11314830-000000000-00000"},{"key":"2016123117301577000_109.6.djw281.37","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.17.1591"},{"key":"2016123117301577000_109.6.djw281.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1213755"},{"key":"2016123117301577000_109.6.djw281.39","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.18.1860"},{"key":"2016123117301577000_109.6.djw281.40","unstructured":"Howlader N Noone AM Krapcho M , SEER Cancer Statistics Review, 1975\u20132013, National Cancer Institute. Bethesda, MD, http:\/\/seer.cancer.gov\/csr\/1975_2013\/, based on November 2015 SEER data submission, posted to the SEER web site, April 2016. Accessed May 15, 2016."},{"key":"2016123117301577000_109.6.djw281.41","first-page":"62","article-title":"Coronary heart disease and stroke deaths - United States, 2006. MMWR. Surveillance summaries: Morbidity and mortality weekly report. Surveillance summaries\/CDC","volume":"60(suppl)","author":"Keenan","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"19","key":"2016123117301577000_109.6.djw281.42","first-page":"1","article-title":"Deaths: Final data for 2007","volume":"58","author":"Xu","year":"2010","journal-title":"Natl Vital Stat Rep"},{"key":"2016123117301577000_109.6.djw281.43","unstructured":"National Cancer Institute. Common terminology criteria for adverse events v 4.0. May 29, 2009. NIH publication # 09-7473."},{"key":"2016123117301577000_109.6.djw281.44","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1720"},{"key":"2016123117301577000_109.6.djw281.45","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000156862.33341.45"},{"key":"2016123117301577000_109.6.djw281.46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.986349"},{"key":"2016123117301577000_109.6.djw281.47","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23139"},{"key":"2016123117301577000_109.6.djw281.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.06.030"},{"key":"2016123117301577000_109.6.djw281.49","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28609"},{"key":"2016123117301577000_109.6.djw281.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.03.033"},{"issue":"6","key":"2016123117301577000_109.6.djw281.51","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1016\/S1470-2045(12)70084-0","article-title":"Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: The standard of care?","volume":"13","author":"Zumsteg","year":"2012","journal-title":"Lancet Oncol."},{"key":"2016123117301577000_109.6.djw281.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2015.08.026"},{"key":"2016123117301577000_109.6.djw281.53","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(01)01441-8"},{"issue":"6","key":"2016123117301577000_109.6.djw281.54","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.brachy.2015.08.004","article-title":"Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy","volume":"14","author":"Raldow","year":"2015","journal-title":"Brachytherapy."},{"issue":"17","key":"2016123117301577000_109.6.djw281.55","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1200\/JCO.2001.19.17.3750","article-title":"Quality-of-life outcomes after primary androgen deprivation therapy: Results from the Prostate Cancer Outcomes Study","volume":"19","author":"Potosky","year":"2001","journal-title":"J Clin Oncol"},{"key":"2016123117301577000_109.6.djw281.56","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9701700201"},{"key":"2016123117301577000_109.6.djw281.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.06.022"},{"key":"2016123117301577000_109.6.djw281.58","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.3369"},{"key":"2016123117301577000_109.6.djw281.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.01.021"},{"key":"2016123117301577000_109.6.djw281.60","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.3752"},{"key":"2016123117301577000_109.6.djw281.61","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1745"},{"key":"2016123117301577000_109.6.djw281.62","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.3.289"},{"key":"2016123117301577000_109.6.djw281.63","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.0662"},{"key":"2016123117301577000_109.6.djw281.64","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.0968"}],"container-title":["Journal of the National Cancer Institute"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:10:17Z","timestamp":1498342217000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djw281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,31]]},"references-count":64,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,12,31]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.1093\/jnci\/djw281"],"URL":"https:\/\/doi.org\/10.1093\/jnci\/djw281","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,31]]}}}